Deleterious effects of endocrine disruptors are corrected in the mammalian germline by epigenome reprogramming by Khursheed Iqbal et al.
Iqbal et al. Genome Biology  (2015) 16:59 
DOI 10.1186/s13059-015-0619-zRESEARCH Open AccessDeleterious effects of endocrine disruptors are
corrected in the mammalian germline by
epigenome reprogramming
Khursheed Iqbal1†, Diana A Tran1,2†, Arthur X Li3, Charles Warden1, Angela Y Bai1,4, Purnima Singh1, Xiwei Wu1,
Gerd P Pfeifer5,6 and Piroska E Szabó1,6*Abstract
Background: Exposure to environmental endocrine-disrupting chemicals during pregnancy reportedly causes
transgenerationally inherited reproductive defects. We hypothesized that to affect the grandchild, endocrine-disrupting
chemicals must alter the epigenome of the germ cells of the in utero-exposed G1 male fetus. Additionally, to affect the
great-grandchild, the aberration must persist in the germ cells of the unexposed G2 grandchild.
Results: Here, we treat gestating female mice with vinclozolin, bisphenol A, or di-(2-ethylhexyl)phthalate during the
time when global de novo DNA methylation and imprint establishment occurs in the germ cells of the G1 male fetus.
We map genome-wide features in purified G1 and G2 prospermatogonia, in order to detect immediate and persistent
epigenetic aberrations, respectively. We detect changes in transcription and methylation in the G1 germline immediately
after endocrine-disrupting chemicals exposure, but changes do not persist into the G2 germline. Additional analysis
of genomic imprints shows no persistent aberrations in DNA methylation at the differentially methylated regions of
imprinted genes between the G1 and G2 prospermatogonia, or in the allele-specific transcription of imprinted genes
between the G2 and G3 soma.
Conclusions: Our results suggest that endocrine-disrupting chemicals exert direct epigenetic effects in exposed fetal
germ cells, which are corrected by reprogramming events in the next generation. Avoiding transgenerational inheritance
of environmentally-caused epigenetic aberrations may have played an evolutionary role in the development of dual
waves of global epigenome reprogramming in mammals.
Keywords: endocrine disruptor, germline epigenetic reprogramming, DNA methylation, vinclozolin, bisphenol A, DEHP,
transgenerational epigenetic inheritance, fetal germ cell, genomic imprintingBackground
Humans are broadly exposed to synthetic endocrine-
disrupting chemicals (EDs) from the environment [1-5].
EDs closely resemble endogenous hormones in structure
and have been reported to cause developmental and
reproductive health problems [6-10]. EDs have the ability
to affect gene expression and DNA methylation [11]. It
has been suggested that one initial exposure to EDs in* Correspondence: piroska.szabo@vai.org
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unless otherwise stated.utero harms multiple generations in rodents and that the
underlying mechanism is epigenetic [6,12-14]. However,
the molecular mechanisms mediating such ED exposure-
dependent transgenerational inheritance in the germline
have not been identified.
In utero ED exposure may harm epigenetic remodeling
events (Figure 1) in the germline of the embryo or fetus
[15]. In the mouse, such events include global erasure of
DNA methylation in primordial germ cells (PGCs) in
embryos of both sexes [16-18] and de novo establishment
of the sperm-type DNA methylation in fetal male germ
cells (MGCs) [19]. De novo DNA methylation in the
female germline may be less vulnerable to in uterohis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Figure 1 Assessing ED effects on imprint reprogramming in the mouse germline. (Top) Reprogramming in the mouse germline. Exposure
of pregnant mice to EDs may directly affect the G0 dam and the G1 soma and G1 germline, and indirectly, the G2 soma that develops from G1
germ cells. DNA methylation patterns are globally remodeled during gametogenesis in both male (above) and female (below) embryos/fetuses in
the chromosomes that are paternally (blue) or maternally (red) inherited. The 5-methylcytosine levels (blue and pink curves) are globally reduced
in the primordial germ cells (PGC) of both sexes; DNA methylation of imprinted DMRs is similarly erased (brown horizontal arrow) by mid-
gestation (13.5 dpc). In the male germ cells, global DNA methylation is largely reset and paternal imprints are newly established (blue arrow) in
prospermatogonia prior to birth and maintained (black horizontal arrows) into spermatozoa (SPZ). In female germ cells, global DNA methylation
and maternal imprints are established (red arrow) after birth during oocyte (OO) growth (from 5 to 20 dpp). The imprinting marks are maintained
(black arrows) through global remodeling at fertilization and embryo development. (Bottom) Daily gavage was given to pregnant dams in the
time windows of ‘Exposure A’ or ‘Exposure B’ to affect the erasure phase of the germline reprogramming in PGCs or the establishment phase in
MGC. The timeline (not to scale) is marked with gestational age (dpc) on top, and also with the age after birth (dpp) at the bottom. In our related
publication [32], maintenance of imprinting was analyzed in the exposed G1 soma after ‘Exposure A’. In the current study, we focused on the
effect of EDs on imprinting via the exposed G1 germ cells. Experimental endpoints are indicated by the arrows pointing down.
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oocytes of the juvenile female [20,21].
An important part of the germline remodeling process is
the resetting of genomic imprints (Figure 1). Imprinted
genes control important developmental processes, including
pre- and postnatal growth, metabolism, and behavior.
Failure to reprogram imprinted genes in the germ line due
to a compromised in utero environment is of special
concern [22-24]. Parental allele-specific monoallelic
transcription of imprinted genes in the soma mainly
depends on the resetting - erasure and re-establishment -
of their differentially methylated regions (DMRs) in the
male and female germlines [25]. DNA methylation marks
at DMRs are erased in PGCs in both sexes by 13.5 days
post coitum (dpc) (Figure 1) [26,27]. Erasure of imprints
results in a shift from monoallelic to biallelic expression
of imprinted genes [28,29]. Re-establishment of the male-
specific DNA methylation marks occurs at paternally
methylated (PAT) DMRs in prospermatogonia and this
methylation is thereafter maintained to the spermatozoa
stage [30]. Whereas PAT DMRs appear to follow the
default global pattern of de novo DNA methylation in
prospermatogonia, MAT DMRs in the same cells are
protected from de novo DNA methylation at sites of H3K4
methylation [19]. Sperm- or oocyte-specific imprinting
marks continue to be maintained following fertilizationduring the global wave of epigenetic remodeling that takes
place in the zygote and early embryo [31] and are further
maintained in the soma in the paternally and maternally
inherited chromosomes.
Several studies have reported that the process of genomic
imprinting is perturbed by endocrine disruptors. The main-
tenance of imprinting in the in utero exposed embryo is
largely resistant but not completely immune to the effects
of EDs, as can be seen from the minor aberrations and in-
creased noise in allele-specific transcription of imprinted
genes [32]. PGCs at 12.5 dpc exhibit an accelerated
imprint erasure rate at the Igf2r, Peg3, and H19 DMRs
after in utero BPA exposure [33]. In utero exposure to VZ
led to decreased DNA methylation of PAT DMRs in mouse
spermatozoa [6,34,35] in the exposed and further genera-
tions, suggesting that the establishment and erasure steps
were both disturbed. The establishment step of maternal
imprints was affected in mouse oocytes: BPA administration
to juvenile females caused a reduction in CpG methylation
at the Igf2r- and Peg3 MAT DMRs [36]. The maintenance
step of genomic imprinting was perturbed in the offspring
after BPA exposure of mothers shortly before and during
pregnancy [37]. Human severe azoospermia is associated
with DNA methylation imprint defects at the H19-IGF2
DMR [38,39], but it is not known whether EDs have a role
in these aberrations.
Iqbal et al. Genome Biology  (2015) 16:59 Page 3 of 24We hypothesized that any epigenetic aberration causing
transgenerationally inherited phenotype in G2 and G3
individuals after in utero exposure of the male G1 germline
must meet the following criteria: (1) it is present in the fetal
G1 germ cell immediately after exposure; (2) it persists into
the G1 gamete; and (3) it persists into the unexposed G2
fetal germ cell of the next generation. In this study, we
sought to detect such immediate and persistent aberrations.
We analyzed in utero-exposed G1 prospermatogonia and
unexposed G2 prospermatogonia to detect immediate and
persistent effects of EDs on global transcription. We
searched for immediate and persistent changes in DNA
methylation in G1 and G2 prospermatogonia and also in
G1 and G2 adult spermatozoa. To further analyze the
effects of EDs on the imprinting process we also
followed the potential germline epigenetic aberration
into the G2 and G3 soma. Our data collectively show that
the male germline suffers from immediate epigenetic
effects after in utero BPA, DEHP, and VZ exposure
but recovers in the subsequent generation.
Results
The aim of this study was to systematically and rigorously
evaluate the effects of EDs on global epigenetic reprogram-
ming and imprint resetting in the male germline after in
utero exposure. We chose three EDs: vinclozolin(VZ) at
100 mg/kg/day; di-(2-ethylhexyl) phthalate (DEHP) at
750 mg/kg/day; and bisphenol A (BPA) at 0.2 mg/kg/day.
These in utero doses have been reported to cause morpho-
logical or physiological defects, including reproductive
harm in the G1 fetuses (see Methods section).
Testing the effect of EDs on imprint erasure
We treated pregnant dams daily from 8.5 dpc to 12.5
dpc (exposure A in Figure 1) with one of the EDs or
with corn oil as control. For this experiment we used
JF1 females and OG2 males (Figure 2A). The OG2 trans-
genic line carries an Oct4 promoter-GFP transgene that
allowed us to purify the GFP-positive male and female
germ cells (MGCs and FGCs) and GFP-negative somatic
cells (MSCs and FSCs) from the dissected embryonic
gonads by FACS sorting (Figure 2B). The JF1 inbred
mouse strain is genetically distinct from the OG2 line,
providing single nucleotide polymorphisms. This allowed
measurement of the allele-specific transcription of known
imprinted genes in JF1 × OG2 cells using multiplex
RNA-single nucleotide primer extension (SNuPE) assays
uisng Sequenom allelotyping [32].
We observed correct parental allele-specific transcrip-
tion in control-treated FSCs and MSCs at 13.5 dpc for
ubiquitously imprinted transcripts; for example, Kcnq1ot1,
Peg3, Plagl1, and Dlk1 were expressed from the paternal
OG2 allele, and Igf2r, H19, and Meg3 were expressed from
the maternal JF1 allele (Figure 2C and Additional file 1).These expression patterns represent the normal correct
ubiquitous parental allele-specific transcription. Some
other transcripts (Kcnq1, Phlda2, and Atp10a, for ex-
ample, which have tissue-specific or developmental
stage-specific imprinting) displayed biallelic transcrip-
tion in FSCs and MSCs. The parental allele-specific tran-
scription in PGCs at 9.5 dpc switched to biallelic
transcription in control FGCs and MGCs at 13.5 dpc, con-
sistent with the erasure of genomic imprints.
Looking at the erasure of allele-specific transcription
in ED-treated FGCs and MGCs, we found few aberra-
tions that were greater than 5% and were statistically sig-
nificant (Student’s t-test, P <0.05) (Table 1). Meg3 was
affected by BPA in FGCs and by VZ in MGCs; H19 was
affected by DEHP in FGCs; and Zim1 was affected by
DEHP in FGCs. Considering the number of tests (28
SNPs tested), we could expect one or two positive re-
sults for each ED in each cell type simply by chance (P
<0.05); the number we found was close to that expect-
ation. Nesp and Asb4 appeared to have a change, but
these genes did not exhibit correct parental allele-
specific transcription in PGCs (Figure 2C). Therefore,
these cannot be considered as erasure defects. Using
multiple testing, we found that none of the erasure
defects were significant for any of the EDs using the
Bonferroni corrected P value (P <0.05/28 = 0.0018).Effect of EDs on allele-specific DMR methylation in
embryos derived from exposed prospermatogonia
In utero ED exposure can perturb the imprinting process
in fetal germ cells at the time when genomic imprints
are established at PAT DMRs and when MAT DMRs
are protected from de novo DNA methylation. Such
perturbation in the normal imprint establishment
process in male germ cells would result in reduced de
novo methylation at PAT DMRs in the prospermatogonia
of G1 fetuses and reduced methylation in the paternally
inherited allele in the soma of the G2 generation. Changes
at MAT DMRs would mean lack of protection from DNA
methylation in G1 prospermatogonia and consequently
their increased methylation in the paternally inherited
chromosome in the G2 generation. We anticipated
that inherited epigenetic changes would result in
aberrant DNA methylation of the same DMR in more
than one organ.
To test whether ED exposure perturbs the imprinting
process in the prospermatogonia, we first tested the allele-
specific DNA methylation pattern at DMRs in the soma of
the derived offspring. G1 129S1 male offspring were ex-
posed in utero at the time of paternal imprint establish-
ment (exposure B in Figure 1) on five consecutive days,
12.5 to 16.5 dpc, by oral gavage to pregnant G0 dams with



















































































Figure 2 Testing the effect of endocrine-disrupting chemicals (EDs) on imprint erasure. (A) Experimental design. JF1 females (tail up) were
mated with OG2 males (tail down). Pregnant dams (G0) were treated with EDs or oil control from 8.5 dpc to 12.5 dpc. Imprint erasure occurs
during this time in PGCs of the exposed G1 embryos. One orange star = exposed G0 generation; two orange stars = exposed G1 embryo. (B) GFP
positive male and female germ cells and somatic cells were collected from the gonads by FACS sorting. (C) Results of RNA Sequenom
allelotyping experiments of imprinted transcripts are displayed for cells treated with an ED or control vehicle (‘oil’); letters in parentheses indicate
separate SNPs. Average (n = 3) allele-specific transcription is shown in color, 100% paternal (blue) to 100% maternal (red), with 50% biallelic in
yellow. Many imprinted genes have parental allele-specific transcription in PGCs at 9.5 dpc but biallelic transcription in FGCs and MGCs (but not
in FSCs and MSCs) at 13.5 dpc. Statistically significant (P <0.05) aberrations in erased allele-specific transcription, greater than 5% or 10%, are marked by
thin or bold white rectangles, respectively.
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mated with unexposed JF1 females to generate G2 off-
spring derived from the exposed prospermatogonia. The
JF1 × 129 G2 fetuses were dissected at 13.5 dpc to
collect head, heart, liver, lung, placenta, yolk sac,and embryo carcass. We isolated DNA and collected
the CpG-methylated fraction using MIRA [40]. We
quantified the percentage of parental alleles in the total
methylated fraction at 14 DMRs (18 SNPs) using
multiplex SNuPE assays [41]. The average percentage
Table 1 Significant changes between control and ED-treated samples after disturbing G1 germ line imprint erasure - RNA
% MAT allele Avg. (n = 3)
Transcript Cell type ED Difference (%) SD (%) Student’s t-test P value Imprinted base line (cutoff 80%) Oil Treatment
Nesp MGC VZ -9.1 3.440 0.004 NO (erased) 39 30
Nesp FGC BPA -8.2 4.356 0.042 NO (erased) 38 30
Nesp MGC BPA -7.9 0.956 0.001 NO (erased) 39 31
Asb4 MGC DEHP 8.7 3.769 0.049 NO (erased) 54 63
Zim1 FGC DEHP 9.0 5.406 0.030 NO (erased) 52 61
H19 FGC DEHP 10.6 7.507 0.024 NO (erased) 65 75
Meg3 FGC BPA 13.7 4.713 0.016 NO (erased) 65 79
Meg3 MGC VZ 16.8 4.438 0.002 NO (erased) 73 90
Allele-specific transcription was compared between ED- and vehicle-treated samples for each transcript in 13.5 dpc FGC and MGC using SNuPE assays. Changes
in the average (n = 3) allele-specific transcription that were greater than 5% and were statistically significant (P <0.05) were tabulated and ordered according to
the difference in maternal allele-specific expression. Baseline allele specificity of transcription in the maternal (MAT) or paternal (PAT) allele was not observed (NO)
in the vehicle-treated sample (cutoff 80%), indicating erased imprinting in PGCs. Of those with baseline erasure, the expression or DNA methylation became more
biased toward one parental allele in a few instances, indicating a lack of proper erasure of imprinted expression (see the last column).
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in Figure 3C and Additional file 1. From 378 different
experimental conditions (7 organs, 3 EDs, 18 SNPs),
we found only four statistically significant differences
(P <0.05) that were greater than 5% (Table 2), and no
difference was higher than 10%. The CpG methylation
was less paternally biased in G2 embryos at 13.5 dpc at
the IG-DMR in the lung; the Peg1-Mest, Nespas, and
Slc38a4 DMRs were less maternally biased in the head,
embryo carcass, and lung, respectively, after VZ treatment
of the prospematogonia of G1 fetuses. Applying multiple
testing, none of these changes were significant using the
Bonferroni corrected P value (P <0.0027). Additional SNPs
in two of these DMRs (IG-DMR and Nespas) did not
substantiate the epigenetic aberration. We did not detect
any change in the G2 soma after BPA or DEHP treatment
of G1 prospermatogonia.
We also carried out the control experiment to test
whether in utero EDs perturb the imprinting process in fe-
male fetal germ cells, which would result in increased de
novo methylation at PAT DMRs in primary oocytes of G1
fetuses. That methylation could be carried into the
soma of G2 generation in the maternally inherited al-
lele of PAT DMRs. Perturbation at MAT DMRs
would cause earlier DNA methylation in oocytes
but would not be expected to change the final
DNA methylation levels of the oocyte nor to in-
crease DNA methylation in the maternally inher-
ited chromosome in the G2 generation. We
exposed the 129S1 G1 female offspring to an ED
or vehicle control (Figure 3B) in utero. We crossed
G1 adult females with unexposed JF1 males to
generate G2 offspring, deriving from the exposed
primary oocytes. We dissected the G2 fetuses at
13.5 dpc and collected seven organs/body parts for
DNA isolation. We measured the parental allele-
specific DNA methylation at 14 DMRs usingMIRA-SNuPE assays (Figure 3D and Additional file
1). We found five significant changes in the mater-
nal allele-specific methylation (>5%, P <0.05) at
PAT DMRs (Table 2). The IG-DMR in the liver and
head was affected by VZ exposure; the Rasgrf1
DMR was affected in the head and heart by DEHP
and in the head by VZ exposure of fetal oocytes. One
of these, the IG-DMR in G2 liver was significant after
Bonferroni correction of P value to P <0.0027. How-
ever, this aberration was not substantiated by another
SNP in the same DMR.
We found 10 cases in which maternal allele-specific
methylation decreased at MAT DMRs by at least 5%
(P <0.05), and two remained significant after Bonferroni
adjustment (P <0.0027). However, these aberrations in G2
soma cannot be explained by disturbed DNA methylation
in fetal oocytes. Another layer of epigenetic regulation
may have been disturbed to prevent the full de novo DNA
methylation of MAT DMRs in growing oocytes after
the birth of the G1 females. It is quite possible that
ED exposure in G0 affects the ability of G1 females
to reproduce by altering the uterine environment, and
thus it may affect G2 independent of the germline.
Since this experimental model is not as ‘clean’ when
addressing germline inheritance as the male inheritance
model (where there is no confounding uterine environment
effect), these data should be interpreted with caution.
Effect of EDs on allele-specific expression of imprinted
genes in embryos derived from exposed
prospermatogonia
We expected that any epigenetic aberration - DNA
methylation or other - occurring in G1 prospermatogonia
at PAT or MAT DMRs would result in misexpression of
imprinted genes in the soma of the G2 generation. To test
for this possibility, we followed the experimental design
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Figure 3 (See legend on next page.)
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Figure 3 Testing the effect of EDs on imprint establishment by assaying the allele-specific DNA methylation at DMRs in G2 embryos.
(A) In utero exposed male 129S1 G1 fetuses were grown to adulthood and mated with unexposed JF1 females; the resulting G2 fetuses
(three blue stars) derived from exposed prospermatogonia. (B) In utero exposed G1 females were mated with unexposed JF1 males to
generate G2 offspring (three red stars) which derived from exposed primary oocytes. G2 fetuses were dissected at 13.5 dpc to collect organs.
(C, D) MIRA-SNuPE results of 13.5 dpc G2 embryo DNA samples after potential paternal and maternal transmission of aberrant DNA
methylation at DMRs. The heatmap shows the percentage of average parental allele-specific methylation in organs; the color scale is as in Figure 2C.
Letters in parentheses indicate different SNPs. Statistically significant differences relative to control (oil) greater than 5% and 10% are indicated by thin
or bold rectangles, respectively (Student’s t-test, P <0.05).
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multiplex Sequenom allelotyping assays at 56 SNPs. The
results are provided in Additional file 1 and are displayed
in two heatmaps (Figure 4). Analyzing three G2 individuals
from each treatment, seven organs, and 56 SNPs, we gen-
erated 4,704 data points and compared the average values,
finding five differences greater than 5% relative to control
(Student’s t-test, P <0.05). None of these differences
remained significant after multiple testing using Bonferroni
correction of P values (P <0.0009). To test for possible
inter-litter variations, we repeated this experiment
with a larger number of G2 fetuses, selected organs,
and selected SNPs, generating 1,350 data points
(Additional files 1 and 2A); there were no differences
greater than 5% relative to control (P <0.05). We
conclude that allele-specific transcription was undis-
turbed in the G2 embryos derived from ED-exposed
prospermatogonia.
We found no causative relationship between aberrations
in allele-specific DNA methylation at DMRs and allele-
specific transcription. For example, the IG-DMR was
affected by VZ in lung (Figure 3C), but transcription of
Meg3, Rtl1/Rtl1as, Rian, and Rian extension, all regulated
by IG-DMR, were not altered there (Figure 4). Similarly,
the Nespas DMR was altered by VZ in the embryo carcass,
but the allele-specific transcription of Nesp, Nespas, and
Gnasxl showed no change.
Testing for transgenerational inheritance of aberrant
imprinting
There were a few statistically significant perturbations in
the transcription of imprinted genes in G2 heart and
lung greater than 5% (Figure 4). We asked whether these
could be passed from G2 individuals into the unexposed
G3 generation. Our experimental design is shown in
Figure 5A. We treated G1 male offspring in utero daily
from 12.5 dpc to 16.5 dpc, when paternal imprint is
occurring in prospermatogonia, with an ED or with
vehicle control (‘oil’). We crossed adult G1 129S1
males with unexposed 129S1 females and allowed G2
males to reach adulthood. Then we crossed them
with unexposed JF1 females to generate G3 offspring.
Whereas G2 fetuses developed from ED-exposed germ
cells, G3 fetuses developed from unexposed gametes.We dissected the heart and lung of JF1 × 129 G2 fe-
tuses at 13.5 dpc and we quantified parental-specific
transcription in the total RNA using multiplex SNuPE
assays (Figure 5B and Additional file 1).
Changes that occurred in the G2 generation did not
carry into G3. We found no statistically significant change
(P < 0.05) greater than 5% in the paternal allele-specific
transcription of Usp29 in the heart (BPA) or Rasgrf1 in
the lung (VZ). We found three statistically significant
changes (in Snrpn, Nespas, and Rtl1/Rtl1as) in G3 lung
after VZ exposure of G1 prospermatogonia (Table 2), but
these must be independent of the initial VZ expos-
ure, because we did not find any misexpression of
their transcripts in the G2 embryo. To test for inter-
litter variation, we repeated this experiment using a
larger number of G3 fetus livers and selected SNPs
(Additional files 1 and 2B). In this dataset, we did not
detect any difference greater than 5% as relative to oil
control (P <0.05). Thus, our results do not support
the hypothesis that ED-triggered epigenetic aberra-
tions in imprint establishment of prospermatogonia
are transgenerationally inherited.
Effect of EDs on allele-specific expression of imprinted
genes in embryos derived from exposed primary oocytes
We used the experimental design shown in Figure 3B
to expose G1 129S1 female offspring to an ED or
vehicle control in utero. We crossed G1 adult females
with unexposed JF1 males to generate G2 offspring
that were from exposed primary oocytes. We dis-
sected JF1 × 129 G2 fetuses at 13.5 dpc, collected
seven organs/body parts for RNA isolation, and mea-
sured the parental allele-specific DNA methylation at
33 SNPs using RNA-SNuPE assays (Additional files 1
and 3). We found four significant decreases in ma-
ternal allele-specific transcription of more than 5%
(Table 2): Slc22a3 and Gnasxl in the yolk sac after
DEHP exposure, Nesp in the placenta (DEHP), Ascl2
in the liver (VZ). None of these remained statistically
significant after multiple testing using the Bonferroni
corrected P value (P <0.0015). We found no causative
relationship between aberrant allele-specific DNA
methylation at DMRs and aberrant allele-specific
transcription (Figure 3D and Additional file 3).
Table 2 Significant changes between control and ED-treated samples after disturbing G1R DMR establishment
% MAT allele
Organ ED Difference (%) SD (%) Student’s t-test P value Imprinted base line Oil Treatment
G2 soma trough paternal germ line - DMR DNA methylation (Figure 3C)
Peg1-Mest Head VZ -9.1 2.523 0.038 YES (MAT) 95 86
Nespas Embryo VZ -6.9 3.150 0.022 YES (MAT) 91 84
Slc38a4 (b) Lung VZ -5.9 1.747 0.006 YES (MAT) 94 88
IG-DMR Lung VZ 5.1 1.513 0.010 YES (PAT) 5 10
G2 soma through maternal germ line - DMR DNA methylation (Figure 3D)
Peg10 Placenta VZ -23.4 3.247 0.000 YES (MAT) 100 77
Peg10 Head VZ -9.5 2.146 0.035 YES (MAT) 95 85
Nespas (a) Yolk sac VZ -8.5 4.049 0.023 YES (MAT) 80 71
Snrpn Placenta VZ -8.4 4.675 0.049 YES (MAT) 95 86
Snrpn Head VZ -7.7 2.521 0.020 YES (MAT) 94 86
Zac1 (a) Yolk sac DEHP -7.3 2.129 0.037 YES (MAT) 83 76
KvDMR1 Head BPA -7.2 1.497 0.001 YES (MAT) 100 93
Peg3 Head VZ -6.4 2.483 0.034 YES (MAT) 99 92
Zac1 (a) Placenta VZ -5.9 3.248 0.036 NO 73 67
Zac1 (b) Placenta VZ -5.7 2.239 0.018 NO 66 61
Peg3 Yolk sac VZ -5.6 2.541 0.022 YES (MAT) 88 83
Zac1 (a) Head VZ -5.5 1.528 0.036 YES (MAT) 85 79
Rasgrf1 Head VZ 5.4 1.343 0.003 YES (PAT) 6 12
Rasgrf1 Head DEHP 5.5 2.038 0.011 YES (PAT) 6 12
Rasgrf1 Heart DEHP 6.4 1.413 0.003 YES (PAT) 15 22
IG-DMR (a) Liver VZ 9.0 1.087 0.002 YES (PAT) 9 18
IG-DMR (a) Head VZ 11.2 3.210 0.048 YES (PAT) 4 15
G2 soma through paternal germ line - RNA transcripts (Figure 4)
Nesp Lung DEHP -14.3 2.166 0.001 NO 45 31
Nesp Heart DEHP -11.9 3.157 0.042 NO 45 33
Slc22a3 Head VZ -7.8 2.097 0.027 NO 53 46
Ascl2 Liver VZ -7.1 3.323 0.043 NO 77 70
Cdkn1c Embryo BPA -6.7 2.865 0.036 YES (MAT) 99 92
Slc22a3 Liver VZ -6.0 2.261 0.011 NO 57 51
Slc22a3 Liver BPA -6.0 2.925 0.025 NO 57 51
Cdkn1c Embryo VZ -5.8 1.367 0.021 YES (MAT) 99 93
Cdkn1c Embryo DEHP -5.8 0.535 0.014 YES (MAT) 99 93
Slc22a3 Lung BPA -5.7 2.710 0.031 NO 64 58
Usp29 Lung BPA 5.7 1.424 0.040 YES (PAT) 3 9
Gnasxl Heart VZ 6.3 1.940 0.027 NO 26 32
Rasgrf1 Heart VZ 9.0 0.722 0.006 YES (PAT) 18 27
Gnasxl Lung VZ 15.3 3.644 0.002 NO 31 46
G2 soma through maternal germ line - RNA transcripts (Additional file 3)
Nesp Placenta DEHP -12.7 4.922 0.034 YES (MAT) 80 67
Slc22a3 Yolk sac DEHP -11.0 0.620 0.030 YES (MAT) 97 86
Ascl2 Liver VZ -9.4 1.324 0.034 NO 71 61
Gnasxl Yolk sac DEHP -8.6 3.204 0.035 NO 52 43
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Table 2 Significant changes between control and ED-treated samples after disturbing G1R DMR establishment
(Continued)
G3 soma through paternal germ line (lung and heart) - RNA transcripts (Figure 5B)
Cobl Heart BPA -28.0 2.289 0.004 NO 79 51
Cobl Heart VZ -27.9 0.640 0.001 NO 79 51
Cobl Lung VZ -19.7 2.033 0.005 NO 70 51
Cobl Lung BPA -19.4 2.729 0.018 NO 70 51
Phlda2 Lung VZ -11.8 3.974 0.032 NO 79 68
Cobl Heart DEHP -11.1 1.206 0.003 NO 79 68
Rtl1/Rtl1as Lung BPA -10.0 1.649 0.021 YES (MAT) 90 80
Tnfrsf22 Heart VZ -9.9 1.942 0.026 NO 58 48
Rtl1/Rtl1as Lung VZ -8.7 4.378 0.007 YES (MAT) 90 81
Tnfrsf22 Heart BPA -8.1 1.070 0.022 NO 58 50
Tnfrsf22 Lung BPA -7.6 1.305 0.023 NO 57 49
Ascl2 Heart DEHP -6.2 2.372 0.011 NO 54 48
Tnfrsf22 Lung VZ -5.5 2.043 0.025 NO 57 51
Atp10a Heart VZ 5.1 1.285 0.010 NO 48 53
Sfmbt2 Lung VZ 6.5 0.690 0.003 NO 41 48
Zim1 Lung BPA 6.7 1.473 0.010 YES (MAT) 90 97
Snrpn Lung VZ 9.9 2.488 0.019 YES (PAT) 11 21
Slc22a3 Lung BPA 10.0 7.898 0.017 NO 50 60
Nespas (a) Lung VZ 10.3 2.375 0.036 YES (PAT) 3 13
Ascl2 Lung BPA 12.7 3.520 0.000 NO 46 59
Asb4 Heart VZ 27.2 8.101 0.019 NO 61 88
Asb4 Heart BPA 27.2 2.591 0.015 NO 61 88
Note: (a) and (b) denote different SNPs for the given DMR or transcript.
Allele-specific DNA methylation or transcription was compared in 13.5 dpc embryos between ED- and vehicle-treated samples for each of the DMRs or imprinted
transcripts, respectively. Changes in the average (n = 3) allele-specific features that were greater than 5% and were statistically significant (P <0.05) were tabulated
and ordered according to the change in the maternal allele. Changes greater than 10% were rare. Baseline allele specificity of transcription or DNA methylation
was observed (YES) or was not observed (NO) in the maternal (MAT) or paternal (PAT) allele in the vehicle-treated sample (cutoff 80%). Of those with baseline
allele specificity, the expression or DNA methylation became less biased (relaxed) in a few instances (see the last column).
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prospermatogonia at DMRs
To test ED effects directly, we used the methylated
CpG island recovery assay (MIRA) chip. We showed
previously that MIRA-chip is sensitive to detect
allele-specific DNA methylation at DMRs in mouse
embryo fibroblasts (MEFs) [42] and to reveal dynamic
DNA methylation changes at DMRs during fetal male
germ cell development [19].
To detect immediate changes in DNA methylation in
male germ cells at the time of exposure and when the
changes are passed to the next generation, we mapped
the methylation patterns from the in utero-exposed
prospermatogonia and the emerging adult spermatozoa
(Figure 6). After crossing a FVB dam and an OG2 father,
we treated G1 male fetuses in utero from 12.5 dpc to
16.5 dpc to daily exposure to an ED or to vehicle con-
trol at the time of paternal imprint establishment in the
prospermatogonia (Additional file 4A). We collectedthe exposed prospermatogonia at 17.5 dpc for DNA
methylation analysis by FACS sorting. We allowed some
G1 males to reach adulthood and collected their sperm
(Additional file 4A). We isolated genomic DNA from
the prospermatogonia and sperm and then we enriched
for the methylated fraction using MIRA. We labeled
the methylated fraction and hybridized it to custom
Nimblegen microarrays that encompassed all known
imprinted domains, as we did earlier [19].
The methylation levels of PAT- and MAT-imprinted
DMRs in prospermatogonia after ED treatment are shown
in Figure 7A. In the controls (‘oil’), DNA methylation re-
programming occurred normally: G1-specific DNA
methylation was erased and the reprogrammed (G1R)-
type DNA methylation establishment was largely complete
(Additional file 5) [19]. DNA methylation was similarly
normal at imprinted DMRs in G1R sperm that developed
from VZ-exposed G1R prospermatogonia (Figure 7B) and
in ED-exposed G1R prospermatogonia (Figure 7A
Figure 4 Effect of EDs on allele-specific expression of imprinted genes in fetuses derived from exposed prospermatogonia.
Experimental design was as in Figure 3A. Results of RNA Sequenom allelotyping experiments of imprinted transcripts) are shown using the
color scale as in Figure 2C; ‘(a)’ and ‘(b)’ denote independent SNPs in the same transcript. Average (n = 3) parental allele-specific transcription is
displayed. Note the overall undisturbed allele-specific transcription. Statistically significant (P <0.05) differences between ED and control greater
than 5% are indicated by thin rectangles. More groups of fetuses are shown in Additional file 2.
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DMRs (Additional file 5A) and valleys were found at MAT
DMRs (Additional file 5B); none of these DMRs showed
any change after ED exposure.
We also tested the G2R male germ cells of the next
unexposed generation derived from exposed G1R
propermatogonia (Additional file 4C and D). We
exposed G1 male fetuses in utero daily from 12.5 dpc to
16.5 dpc to an ED or vehicle control. We allowed someG1 (FVBXFVB) males to reach adulthood and
crossed them with OG2 females to obtain G2 fetuses
(Additional file 4C). These fetuses derived from
exposed G1R prospermatogonia, but their prosperma-
togonia that carried the G2R-type DNA methylation
pattern had never been exposed to EDs. We collected
the G2R-type prospermatogonia for DNA methylation
analysis, and we allowed some VZ-exposed G2 (FVBXOG2)


















































































Figure 5 Testing for transgenerational epigenetic inheritance of the aberrant imprinted expression. (A) Breeding design to test whether
ED-perturbed parental allele-specific transcription is transgenerationally inherited through the paternal germline to an unexposed generation. G1
male fetuses were exposed in utero to EDs or vehicle control (‘oil’) daily from 12.5 dpc to 16.5 dpc. After reaching adulthood, 129S1 G1 males
were mated with 129S1 unexposed females to generate G2 offspring (3 blue stars), which derived from exposed prospermatogonia. At adulthood,
G2 males were mated with unexposed JF1 females to generate G3 offspring, which were never directly exposed to EDs. JF1 × 129 G3 fetuses
were dissected at 13.5 dpc to collect organs for RNA isolation. Parental-specific transcription was quantified in the total RNA using multiplex
SNuPE assays. (B) Results of Sequenom allelotyping experiments using heart and lung tissue of the G3 generation; color scale as in Figure 2;
letters in parentheses denote independent SNPs. Notice the lack of inherited changes from the exposed generation. More groups of fetuses
are shown in Additional file 2. This Figure includes standards that are routinely included in the Sequenom runs (see Methods).
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methylation patterns of these male germ cells at
imprinted DMRs using MIRA-chip. We calculated the
average MIRA/input log2 ratios (n = 3 for MGC andn = 2 for sperm) along known imprinted DMRs in the
custom imprinting arrays (Figure 7A).
As expected, the paternally methylated DMRs had
























Figure 6 Assessing if in utero exposure to ED results in transgenerationally inherited epigenetic aberration via the germline.
(A) Normal epigenetic remodeling the male germline. MGC undergo normal erasure and normal re-establishment of DNA methylation,
producing reprogrammed G1 (G1R) MGCs and G1R spermatozoa. (B) Hypothetical situation where a G1 embryo (two orange stars) exposed to
ED during the de novo DNA methylation process results in aberrant reprogramming of G1R MGCs. The aberrant DNA methylation pattern may
be maintained in G1R spermatozoa. Aberrant DNA methylation pattern of G1R sperm may harm G2 embryos (three blue stars), by germline
epigenetic inheritance. The right panel shows a hypothetical situation in which in the absence of further ED exposure, an aberrant DNA pattern
is inherited from the G1R spermatozoa. This aberration fails to be erased in G2 PGCs, and is carried further into G2R prospermatogonia and G2R
spermatozoa, which have not been exposed directly or indirectly; thus, persistence of the aberration in these cells would constitute transgenerational
epigenetic inheritance. Note that the DNA methylation patterns are simplified, for example, they do not take into account remodeling
during the zygote-early embryo stages (green box). (C) Timing scheme of the genome-wide mapping studies. G1 fetuses were exposed
in utero during the establishment phase (Exposure B), and G1R and G2R fetal MGCs and adult spermatozoa were collected for analysis.
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calculated the change in MIRA intensities between ED-
exposed and control G1R prospermatogonia: no MAT
DMR showed increased methylation and no PAT DMR
showed decreased methylation, using cutoff values of
±5% and P <0.05. We found no changes in G2R-type
prospermatogonia at PAT DMRs after any ED treatment(Additional file 6). There was no detectable change in
G2R-type spermatozoa after VZ treatment (Figure 7B),
and MAT DMRs were similarly unaffected (Additional
file 6). Our data show no evidence for aberrant imprint
establishment in propermatogonia after treatment with
EDs, for its inheritance through the sperm, or for further
transgenerational inheritance to unexposed offspring.
DMR OIL BPA DEHP VZ OIL BPA DEHP VZ OIL VZ OIL VZ






































Figure 7 (See legend on next page.)
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Figure 7 DNA methylation establishment is undisturbed by EDs in prospermatogonia at paternally methylated imprinted DMRs. DNA
methylation was mapped in purified G1R and G2R prospermatogonia and spermatozoa using MIRA-chip and custom Nimblegen imprinting
arrays. The mouse matings were conducted as depicted in Additional file 4. (A) Summary of MIRA-chip results at imprinted DMRs in custom im-
printing arrays (groups 5 to 8). The average MIRA/input log2 ratios (n = 3 for MGCs and n = 2 for sperm) were calculated for known imprinted
DMRs and are depicted with red (maternal and blue (paternal) flags in the range of -1.9 to +1.9. The full calculations are provided in Additional
file 6. Note that paternally methylated DMRs have positive MIRA/input log2 ratios and maternally (MAT) methylated DMRs have negative MIRA/in-
put log2 ratios, as expected. No MAT DMR exhibited increased methylation and no PAT DMR had decreased DNA methylation, using the cutoff
values of ±5% and P <0.05 (Student’s t-test). (B) The MIRA profile is depicted at paternally methylated imprinted DMRs (black rectangles) in bio-
logical duplicate samples for VZ treatment or control. The DNA methylation signals of MIRA versus input DNA were plotted as -log10 P values in
the range of 0 to 8.4. The average % DNA methylation levels at each CpG as determined by whole genome bisulfite sequencing (WGBS) are
shown compared to that of normal MGCs at 16.5 dpc [18] and normal sperm [20]. Note, that DNA methylation at paternal DMRs is undisturbed
by ED treatment in the exposed prospermatogonia and in the prospermatogonia of the next generation.
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after ED exposure of G1 prospermatogonia
To find genome-wide immediate and persistent changes
in DNA methylation, we used a genome-wide methyl-
ated CpG island recovery assay (MIRA) with Nimblegen
CpG-island + promoter arrays (sample groups 1 to 4)
and a custom, imprinting array (sample groups 5 to 7, as
summarized in Additional file 7). The custom array
included known imprinted genes, DMRs, control
genes, IAP-flanking regions, and the Y chromosome.
The log2 ratios of the MIRA/input signal from each
hybridization value were quantified, the average values
were calculated for the biological replicates, and these
values were used in a multi-level data analysis (Table 3
and Additional file 8).
At the first level we tested for changes between pairs
of experimental and control samples. We compared the
log2 ratio MIRA versus input values for each sample ‘A’
with the corresponding sample ‘B’. We identified peaks
in sample ‘A’ first and calculated the difference between
‘A’ and ‘B’ in samples at these locations. We performed
this analysis two ways, calling the experimental sample
‘A’ and control sample ‘B’ and vice versa, to ensure that a
change would be detected at each peak even when it oc-
curred only in ‘A’ or in ‘B’. We chose very low cutoff
values - changes greater than ±5% with Fisher’s exact
test P value (P <0.05) - to allow the higher-level analyses
of a larger set of primary hits. At the second analysis
level, we compared the results of two level-1 tests to find
common changes between G1R and G2R samples. At
level 3, we compared the results of two level-1 tests to
find common changes between MGCs and sperm in the
same generation. At level 4, we compared the results of
four level-1 tests: an immediate effect in G1R MGCs
that persisted into G1R sperm, G2R prospermatogonia,
and G2R sperm, thereby having the potential to affect
the G3 soma.
We found very few hits at levels 2 to 3 and no hits at
level 4, despite the low cutoff values (Table 3 and
Additional file 8). Some examples of the best hits of the
level 2 and 3 analyses are shown in Figure 8A; these hitsare unimpressive and exist at regions with generally low
DNA methylation.
We inspected the locations of the best hits in a recent
study of G3R sperm after initial VZ exposure in G1
MGCs [43]. We found no change in G1R and G2R
MGCs and sperm at Mro and found a complete lack
of DNA methylation at Elf3 (Additional file 9). One
possible explanation for the discrepancies can be
methodological differences. Whereas we hybridized
each biological replicate against input and measured
methylation levels along chromosomes, Guerrero-Bosagna
hybridized control and experimental samples against
each other, measuring differences in each chip, thus
lacking information about DNA methylation levels at
specific regions.
Search for changes in DNA methylation at IAPs
Interesting targets for ED-caused aberrant DNA methy-
lation may be intracisternal A-particle elements (IAPs),
which retain substantial DNA methylation through
the germline erasure process and thus can lead to
transgenerational inheritance (TGI) of epigenetic changes
[18,44]. Because most IAPs become highly methylated by
the spermatozoa stage, it may be the rare unmethylated
IAPs that carry specific information to the respective
transcripts they may affect, and in turn, these may
depend on the protection by H3K4 methylation [19].
We calculated the average DNA methylation along each
unique 1-kb-long IAP-flanking region in the custom
imprinting arrays and identified the DNA methylation
changes at these regions between the exposed and
control-treated samples with cutoff values of ±5% and
P <0.05 (Additional file 10).
To reveal TGI of DNA methylation aberrations, we
searched for common changes at IAP-flank regions be-
tween G1R and G2R in MGC samples after the initial
exposure of G1R MGCs to VZ; those changes are shown
with chromosomal coordinates in Additional file 11.
Similarly, we identified the changes at IAP-flanking re-
gions that were common between VZ-exposed G1R
prospermatogonia and G1R sperm or between G1R and
Table 3 Analysis results for immediate and persistent changes in DNA methylation after ED exposure of G1
prospermatogonia
Analysis level 1 Level 2 Level 3 Level 4
Sample A Sample B Sample A to B Hits Common in
G1R and G2R
Hits Common in MGCs
and sperm
Hits TGI Hits
Group 1: CpG_G1R_MGC Oil BPA Test 1 112 Test A (test 1 v 7) 1 (1)
BPA Oil Test 2 72 Test B (2 v 8) 3 (3)
Oil VZ Test 3 129 Test C (3 v 9) 0 (0) Test Q (3 v 13) 1 (1) Test C v G 0 (0)
VZ Oil Test 4 81 Test D (4 v 10) 0 (0) Test R (4 v 14) 2 (1) Test D v H 0 (0)
Oil DEHP Test 5 130 Test E (5 v 11) 4 (1)
DEHP Oil Test 6 120 Test F (6 v 12) 6 (3)
Group 2: CpG_G2R_MGC Oil BPA Test 7 61
BPA Oil Test 8 98
Oil VZ Test 9 59 Test S (9 v 15) 4 (2)
VZ Oil Test 10 135 Test T (10 v 16) 2 (1)
Oil DEHP Test 11 89
DEHP Oil Test 12 167
Group 3: CpG_G1R_SPERM Oil VZ Test 13 76 Test G (13 v 15) 4 (4)
VZ Oil Test 14 76 Test H (14 v 16) 4 (3)
Group 4:
CpG_G2R_SPERM Oil VZ Test 15 196
VZ Oil Test 16 99
Group 5: Imp_G1R_MGC Oil BPA Test 17 46 Test I (17 v 23) 0 (0)
BPA Oil Test 18 35 Test J (18 v 24) 0 (0)
Oil VZ Test 19 93 Test K (19 v 25) 1 (1) Test U (19 v 29) 1 (1) Test K v O 0 (0)
VZ Oil Test 20 51 Test L (20 v 26) 1 (1) Test V (20 v 30) 0 (0) Test L v P 0 (0)
Oil DEHP Test 21 83 Test M (21 v 27) 0 (0)
DEHP Oil Test 22 59 Test N (22 v 28) 1 (0)
Group 6: Impr_G2R_MGC Oil BPA Test 23 30
BPA Oil Test 24 45
Oil VZ Test 25 29 Test X (25 v 31) 0 (0)
VZ Oil Test 26 120 Test Y (26 v 32) 4 (4)
Oil DEHP Test 27 27
DEHP Oil Test 28 111
Group 7: Impr_G1R_SPERM Oil VZ Test 29 56 Test O (29 v 31) 3 (2)
VZ Oil Test 30 58 Test P (30 v 32) 1 (0)
Group 8: Impr_G2R_SPERM Oil VZ Test 31 114
VZ Oil Test 32 93
After in utero exposure of G1 MGC to vehicle control (‘oil’) or one of the EDs, the level of DNA methylation was measured in reprogrammed G1R and G2R fetal
MGCs and adult spermatozoa by MIRA-chip and Nimblegen microarrays. CpG-promoter arrays were used in groups 1 to 4 and custom imprinting arrays were
used in groups 5 to 7. At the first level of analysis, we performed 32 tests comparing the log2 ratio MIRA versus input values. To detect a change between sample
A and B, peaks were identified in the average value (n = 3 for MGC and n = 2 for sperm) of A samples first and were compared with the MIRA intensity of the
average of sample B at the same locations. The number of hits where a change occurred with greater than ±5% and Fisher’s exact test P value (P <0.05) were
tabulated. At level two, we compared the results of two level-1 tests (in parentheses) to find common changes between G1R and G2R in MGCs (Tests A-F and I-N)
and in sperm (Tests G-H and O-P); the number of common hits is provided and those that changed in the same direction are given in parentheses. At level three,
we compared the results of two level-1 tests to find common changes between MGC and sperm in the same generation, G1R (Test Q-R and U-V) or G2R (S-T and
X-Y). At level four, we compared the results of four level-1 tests in search for true transgenerational epigenetic inheritance: immediate effect in G1R MGCs, main-
tained into G1R sperm, G2R prospermatogonia, and G2R sperm, thereby having the potential to affect G3 soma. Note the low number of hits in levels 1 to 3 and
lack of hits at level 4, even at the low cutoff values applied.

































Figure 8 Selected top hits of transgenerationally inherited DNA methylation aberrations. Prospermatogonia of G1 fetuses were treated
with ED or oil control in utero as depicted in Additional file 4. Next, DNA methylation was mapped using MIRA-chip and custom Nimblegen arrays
in purified G1R and G2R prospermatogonia at 17.5 dpc in triplicate and in adult spermatozoa in duplicate. Immediate and persistent changes are
tabulated in Table 3 and Additional file 8. (A) Selected top persistent hits are shown from the analysis in duplicates labeled at the top according
to the comparisons in Table 3 and marked with arrowheads (up for increase and down for decrease) (B) A selected IAP-flank region where common
changes were detected in MGC samples between G1R and G2R at and between G2R MGC and G2R sperm. (C) The H19-Igf2 imprinted DMR is shown
as a positive control for the DNA methylation signal (black rectangle). DNA methylation signals of MIRA versus input DNA are plotted as -log10 P values
ranging from 0 to 8.3 for experimental and control replicate samples. Note that these top changes are minor and not highly significant.
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identified the common changes in G1R and G2R
prospermatogonia that occurred after initial DEHP or
BPA exposure in G1R (Additional file 10). The changes
were small, often occurred in the opposite direction, and
seldom mapped to gene promoters.
Our MIRA-chip results collectively suggest that BPA,
DEHP, and VZ at the given doses have negligible immedi-
ate and persistent effects on the de novo DNA methylation
process in mouse G1R prospermatogonia at CpG islands,
promoters, imprinted DMRs, IAPs, and along the Y
chromosome.
Search for immediate and persistent changes in
genome-wide transcription after ED exposure of G1
prospermatogonia
Although we found no evidence for TGI at the level of
DNA methylation, other mechanisms such as histone
modifications, histone variants, and long non-coding
RNAs also participate in gene regulation and may
transmit epigenetic aberrations between generations.
Such aberrations are likely manifest in altered gene
expression patterns. Therefore, we carried out Affymetrix
microarray hybridization experiments using RNA from
FACS-sorted 17.5-dpc fetal FGCs and MGCs exposed inutero to BPA, DEHP, VZ, or vehicle control. To find imme-
diate direct responses to ED exposure, we analyzed G1R
fetal oocytes and prospermatogonia. To find persistent
changes, we analyzed G2R prospermatogonia. For the
summary of samples, see Additional file 7.
We found that sex was the main dividing parameter in
principal component analysis (PCA) (Figure 9A), as
expected based on our previous transcription profiling
of fetal germ cells using RNA-seq [19]. We confirmed
the male or female germ cell-specific transcription of
epigenetic modifiers: Mll3 and Ehmt2 were highly
expressed in FGCs and MGCs, respectively, and neither
showed any change in transcription in response to any
of the EDs (Figure 9B). G1R and G2R male germ cells
were slightly separated from each other in the PCA
(Figure 9A), likely because these samples were run at
different times or because of the reciprocal genome
composition (FVB ×OG2 and OG2 × FVB, respectively) of
these cells. Importantly, G1R prospermatogonia samples
were clustered based on treatment type: BPA samples
shifted slightly from control oil samples, and groups of
DEHP and VZ samples shifted further away. Such clustering
of samples was not apparent in G1R female germ cells or
G2R male germ cells (Figure 9A). Using sex as an
internal biological difference, we compared G1R female
Figure 9 Search for immediate and persistent changes in RNA levels after ED exposure of G1 prospermatogonia. G1R prospermatogonia
were purified at 17.5 dpc from female or male fetuses exposed in utero to BPA, DEHP, VZ, or vehicle control (‘oil’) and G2R prospermatogonia
were also purified. Trancription of mRNA was measured using Affymetrix 1.0ST chips and the data were statistically analyzed in the Partek suite. (A)
Principal component analysis of the samples. Note that the major principal component is sex and the second is generation. In addition, G1R male
samples are separated by ED treatment. (B) Selected control transcripts are shown with known reciprocal expression patterns in the two sexes. (C)
Selected top hits are shown that are upregulated in BPA-exposed G1R prospermatogonia. These genes are known targets of β-estradiol.
(D) Selected top hits in VZ- and DEHP-exposed G1R propsermatogonia. Note that the androgen pathway is affected.
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11,848 statistically significant differences (6,552 up in
female, 5,296 up in male) between sexes using 1.5-fold
change and a false discovery rate (FDR) of 0.05
(Table 4). Similar numbers were found when comparingthe respective female and male samples after BPA, DEHP,
and VZ treatment. Notably, we found no overlap in
the female up hits in the controls with the female
down hits in any of the samples. These comparisons
assured us that the data quality and analysis pipeline
Table 4 Search for immediate and persistent changes in RNA transcript levels after ED exposure of G1
prospermatogonia
Cutoff 1.5-fold, P <0.05 Cutoff 1.05-fold, P <0.05
Condition 1 Condition 2 Probesa Probes Unique Common G1R-G2R Probes Unique Common G1R-G2R
Female-Male G1R BPA F G1R BPA M 12,310
G1R DEHP F G1R DEHP M 11,886
G1R VZ F G1R VZ M 11,877
G1R OIL F G1R OIL M 11,848
ED-OIL G1R BPA F G1R OIL F 0 230 14 1,592 933
G1R DEHP F G1R OIL F 0 217 50 2,284 1,590
G1R VZ F G1R OIL F 0 194 20 2,133 1,412
G1R BPA M G1R OIL M 0 247 125 2,552 1,842
G1R DEHP M G1R OIL M 7 292 48 1 (0/1) 5,210 3,639 325 (77/325)
G1R VZ M G1R OIL M 2 549 61 8 (0/8) 6,499 4,295 284 (30/284)
G2R DEHP M G2R OIL M 0 199 12 1 (0/1) 2,456 1,482 325 (77/325)
G2R VZ M G2R OIL M 0 186 16 8 (0/8) 1,912 1,044 284 (30/284)
Average number of probes 264 43 3,080 2,029
aCutoff: 1.5-fold, FDR P <0.05.
Prospermatogonia were purified at 17.5 dpc from female (F) or male (M) fetuses exposed in utero (G1R) to BPA, DEHP, VZ, or vehicle control (‘oil’).
Prospermatogonia were also purified from the next generation (G2R). Trancription of mRNA was measured using Affymetrix 1.0ST chips. Transcription differences
were detected between conditions 1 and 2. The hits are tabulated according the cutoff values, shown in the heading, as probes and unique transcripts. Bold
numbers are higher than average among ED treatments for the given cutoff values. Common changes were detected between the unique transcripts that change
in G1R and G2R samples for the same treatment; the numbers of those that changed in the same direction are in parentheses.
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this sample set.
We generated the counts of differentially expressed
probes and unique transcripts using Ingenuity Pathway
Analysis (IPA) for each ED exposure versus control
(Table 4). Using cutoff values of 1.5-fold change and
FDR P <0.05, we found seven probes and two probes in
the G1R DEHP male and G1R VZ male samples,
respectively, but no probes in the other samples. When
we relaxed the statistical cutoff value to simply P value
<0.05 (with 1.5-fold difference), we found an average of
264 probes per condition; using cutoffs of 1.05-fold and
P value = 0.05, we found an average of 3,080 probes per
condition. We considered these relaxed cutoff values
rather loose and likely to result in false positives. However,
at any cutoff value, G1R DEHP versus control male and
G1R VZ versus control male samples consistently yielded
larger numbers of differences than the average numbers of
other comparisons. In addition, the number of unique
transcripts was higher than average in G1R DEHP versus
control female and G1R BPA versus control male samples.
This suggested that there are subtle transcription changes
in these four conditions that are caused by ED exposure.
IPA analysis revealed that the transcription changes
affected the reproductive or endocrine system in each
case. Interestingly, IPA identified β-estradiol as the
upstream regulator for G1R BPA MGCs, with a probability
of 4.57 × 10-19; four transcripts of the top 10 are regulated
by β-estradiol (Figure 9C). Selected top hits in the maleG1R VZ and DEHP samples are depicted in Figure 9D.
Hydroxysteroid (17-beta) dehydrogenase 3 (Hsd17b3)
was upregulated by BPA and VZ, while androgen
receptor (Ar) was upregulated by VZ and DEHP. These
transcripts are interesting because they play roles in the
androgen pathways.
We noticed that none of the G1R top changes were
detected in G2R (Figure 9). To further search for persistent
changes in transcription, we compared the lists of dif-
ferential expression in G1R MGCs with the respective
G2R samples (Table 4). At the cutoff values of 1.5-fold
and P <0.05, we found only one and eight common
changes for DEHP and VZ, respectively, but none of these
unique transcripts changed in the same direction. At the
cutoff values of 1.05-fold and P <0.05, we found 325 and
284 common changes for DEHP and VZ, respectively.
However, only 77/325 and 30/284 unique transcripts
changed in the same direction, fewer than expected by
chance (Additional file 12). When we considered all
probes with common changes between G1R and G2R,
Fisher’s exact tests revealed that a significantly greater
number of the common changes occurred in the opposite
direction. For DEHP, G0 downregulated (G1:Down)
genes are significantly more likely to be in G1:Up (1.8×,
P = 2.6 × 10-5), and G0:Up genes are significantly more
likely to be in G1:Down (4.0×, P < 2.2 × 10-16). For VZ, G0:
Down genes are significantly more likely to be in G1:Up
(5.4×, P <2.2 × 10-16), and G0:Up genes are significantly
more likely to be in G1: Down (7.2×, P <2.2 × 10-16).
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effects compared with those resulting from sex and
generation number. The changes, however, affected
hormonal pathways for the G1R BPA, G1R DEHP,
and G1R VZ male samples, confirming that the drugs
have reached their targets in fetal germ cells. The ED
treatments had more effect in prospermatogonia than in
fetal oocytes, likely because male germ cells undergo
epigenetic establishment phase at the fetal stages and
the establishment process may be vulnerable to environ-
mental disturbances. VZ and DEHP caused more tran-
scription differences in male germ cells than BPA, possibly
because male germ cells may be more responsive to
androgen signaling than to estrogen signaling. Notably,
no treatment effect on transcription persisted from G1R
to G2R, suggesting that the germ line is capable of
rebounding from epigenetic effects caused by EDs.
Discussion
To date no molecular evidence exists in mammals that
fulfills the following criteria of TGI after in utero exposure:
(1) an epigenetic aberration is detected in the exposed fetal
germ cells; (2) the aberration is retained in the gamete; and
(3) the same aberration is detected in the germ cells of the
next generation. The aim of the present study was to
systematically and rigorously evaluate the effects of EDs on
global epigenetic reprogramming in the male mouse germ
line after in utero exposure. We selected EDs that were
reported to cause epigenetic aberrations, and focused on
three EDs that affect estrogenic and androgenic pathways.
Indeed, our exposures have reached the fetal germ cells, as
we detected specific changes of transcription in G1R MGC
that could be expected based on the known estrogenic
properties of BPA and anti-androgenic properties of DEHP
and VZ. We found that BPA caused the activation of
estrogen-responsive genes, whereas VZ and DEHP induced
elevated Hsd17b3 and Ar transcripts, respectively, in
the exposed G1R MGCs. However, these changes did
not persist into the G2R MGCs. We investigated global
DNA methylation changes at CpG islands, promoters,
imprinted DMRs, and IAP repeats, and we did not find
evidence for persistent changes between G1R and G2R
prospermatogonia.
Even if we encountered a very persistent epigenetic
aberration that occurred in the fetal germline of one
sex and was maintained through several generations,
we would expect to find a dilution of this effect with
every generation, because meiosis results in haploid
gametes and the chance of getting this allele is halved
in every consecutive generation. The only exemption to
this rule would involve the Y chromosome. We found no
persistent changes in global transcription or DNA
methylation between the exposed G1R and the next
G2R generations along the Y chromosome.TGI is perhaps easier to explain in organisms like C.
elegans, where the germline is set aside at the zygote
stage [45]. Even though the C. elegans germline also
undergoes global epigenetic remodeling that mainly
involves erasure and re-establishment of active histone
modifications [46], any epigenetic aberration could be
more easily inherited in the daughter cells that remain
in the germ lineage. Indeed, in C. elegans, deficiencies in
the H3K4me3 chromatin modifiers in the parental
generation extended the life span of three generations in
the wild type descendants [47]. However, in mammals,
the germline develops from progenitors in the proximal
epiblast and these cells have already differentiated away
from the pluripotent state. Any epigenetic aberration has to
resist two global waves of epigenetic reprogramming: the
first occurs after fertilization in the zygote-preimplantation
stage and the second in the primordial germ cells.
Both waves involve erasure of the old patterns and the re-
establishment of new patterns. These two global waves of
remodeling must be the mechanism that removes epi-
genetic damage caused by the environment, ensuring
that these are not inherited into the soma of the G3
generation. It is tempting to speculate whether avoiding
TGI of environmental aberrations played an evolutionary
role in the development of dual global reprogramming
events in mammals.
Conclusions
Our data show that whereas endocrine disruptors affect
the transcription and DNA methylation state of exposed
germ cells, these changes are not found in the germ
cells of the subsequent generation. The genome-wide
epigenetic remodeling processes in the next generation
are robust, allowing the mammalian germline epigenome




Housing and care of the animals were consistent with
Public Health Service Policy, the NIH Guide for the Care
and Use of Laboratory Animals, and the Animal Welfare
Act. All of the animal experiments were approved under
protocol ID 91023 by the IACUC, City of Hope.
Treatment regimens for the selected EDs
Mouse transgenic line TgOG2 [28] and inbred FVB,
129S1, and JF1 mice were used in the various studies.
Animals were housed in polypropylene cages and received
a special verified diet, 5 K96 (TestDiet), as recommended
by the NIH for animal studies involving hormone-like
chemicals. Drinking water was provided in glass bottles
and was purified on a carbon filter (Filter Cartridge Hi-Cap
Carbon 9-3/4 ID #: 2100-1970-102 from Edstrom Direct)
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generation 0 (G0) were gavaged with EDs daily for
5 days starting at 8.5 dpc for the erasure study or at
12.5 dpc for the establishment study.
The EDs used were vinclozolin (ChemService Catalog
no. PS-1049; Sigma, USA), bis(2-ethylhexyl) phthalate
(Selectophore, (DEHP), Catalog no. 80030; Fluka/Sigma
Inc.), and bisphenol A (Catalog no. 239658; Sigma
Aldrich Inc.). All three EDs were dissolved/suspended in
tocopherol-stripped corn oil vehicle (MPI Catalog no.
0290141584). Control animals were treated with the
oil vehicle alone [48,49]. The oral doses for VZ
(100 mg/kg/day), BPA (0.2 mg/kg/day), and DEHP
(750 mg/kg/day) were the same as in our previous
study [32]. These doses to pregnant mice are known
to reach and to affect the fetus. VZ, for example,
given by oral gavage at 10 or 50 mg/kg doses daily
between 13.5 dpc and 17.5 dpc resulted in morphological
changes in mouse fetuses at 19.5 dpc, including
feminization of males (hypospadias) and virilization
(longer urethras) of females together with altered gene
expression in the genital tubercles [50,51]. Even a low dose
of 1 mg/kg, VZ administered to pregnant mice in drinking
water between 15 and 22 dpc resulted in decreased
anogenital distance, prostate weight, relative testis weight,
sperm count, and acrosomal state; caused increased sperm
head abnormalities and pathology of the testes; and
affected the expression of selected genes in male G1
offspring [52]. In utero and lactational exposure to DEHP
at 750 mg/kg/day caused severe male reproductive system
toxicity in rats including reduced sperm count and
testicular malformations [48]. In mice, DEHP administra-
tion to pregnant mouse dams in food at 0.01% or 0.03%
[53] (an estimated 0.75 to 1 g/kg or 2.25 to 3 g/kg/day
dose, respectively), caused fetal defects and reduced the
number of litters and number of live pups. At such daily
doses, the DEHP metabolite MEHP clearly showed
dose-dependent accumulation in 18.5-dpc fetal livers
[54]. Oral administration of a single dose of 10 mg/kg
BPA to pregnant mouse dams resulted in 0.01 mg/L
BPA or 0.03 mg/L total BPA (including metabolite) in
15.5-dpc fetuses in the first hour [55], and three consecu-
tive daily doses were additive. Feeding BPA (0.02 mg/kg)
to pregnant mice at 11.5 to 17.5 dpc significantly
decreased sperm production in the male offspring [8]
and disturbed oocyte development and meiosis in
female fetuses [56]. The same dose of BPA at 11.5 to
14.5 dpc lead to a large number of subtle changes of
transcription in the fetal ovary [57].
Purification of germ cells
Using a MoFlo or Aria III flow cytometer, germ cells
(GFP-positive), and somatic cells (GFP-negative) were
flow-sorted from embryonic or fetal gonads at 9.5, 13.5,or 17.5 dpc based on germ cell-specific EGFP expression
in the TgOG2 transgenic mouse line [28] as described
previously [58]. Phenol red was excluded from the M2
medium. Spermatozoa were collected from the cauda
epididymis of adult FVB males and the motile fraction
was used for MIRA-chip analysis.
DNA isolation and methylated CpG island recovery assay
(MIRA) and MIRA-chip
Genomic DNA was isolated from fetal germ cells by
proteinase K digestion and phenol-chloroform extraction.
Contaminating RNA was removed by RNAse treatment
(Roche). RNA-free genomic DNA was sonicated to 300 to
800 bp using a standard Bioruptor water bath sonicator
(Diagenode). Sonicated DNA (500 ng) was used for MIRA,
as described previously [40]. The methylated fraction
was captured using recombinant MBD2b and MBD3L1
proteins as described earlier [59] and was amplified
by ligation-mediated PCR as previously described
[42]. CpG-promoter arrays and custom-designed tiling
arrays (110228_MM9_PS_ChIP), including all known
imprinted domains and IAP flanking regions (Roche/
NimbleGen), were used for the CpG methylation profile
analysis [19]. Amplified MIRA DNA fractions were
compared with amplified input DNA. Data were extracted
from scanned images by using NimbleScan 2.3 extraction
software (NimbleGen Systems).
Detecting DNA methylation changes in MIRA-chip
To identify statistically significant changes caused by ED
treatment, we compared treated versus oil control and
also oil control versus treated samples in triplicates.
To identify individual peaks in sample A, probes were
considered positive if their normalized log2 ratio was
above the 95th percentile of all probes on the array,
and peaks were defined as four or more consecutive
positive probes allowing one gap. The common peaks
were identified between the triplicates of sample A
and their mean value was compared to that of sample B.
DNA methylation changes were identified based on the
average log2 ratio signal difference between sample A and
sample B, using cutoff values of ±5% (minimum 1.05-fold
increase or 0.95-fold decrease) and Fisher’s exact t-test
P value, P <0.05. To compare DNA methylation levels
at DMRs and IAPs, we calculated the average log2
MIRA/input values along these sequences and compared
them to detect changes between conditions with the cutoff
values of ±5% and P <0.05 (Student’s t-test).
RNA isolation and Affymetrix microarray hybridization
RNA was isolated from germ cells using TRIzol (Qiagen)
extraction followed by ethanol precipitation. The RNA
samples were processed in the City of Hope’s Microarray
Facility using Mouse Gene 1.0 ST arrays (Affymetrix).
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least-squares mean using Partek Genomics Suite. Prior
to statistical analysis, data were normalized using robust
multichip average (RMA) normalization [60]. We used
an ANOVA model with linear contrast to identify
genes that have a change under condition A relative
to condition B, with specific statistical significance
and fold-change values, as specified in the text. We
considered interactions between treatment, sex, and
generation. Microarray data were deposited in GEO:
Super series GSE59543.
RNA isolation and reverse transcription-PCR
RNA was isolated from germ cells and various organs/
body parts using RNA-Bee (Tel-Test). Contaminating
DNA was removed with the DNA-free Kit (Ambion).
cDNA was reverse-transcribed from total RNA using
SuperScript III First-Strand Synthesis kit (Invitrogen).
Analysis of allele-specific DNA methylation and gene
expression by Sequenom allelotyping
Allele-specific DNA methylation and gene expression
was measured by multiplex SNuPE assays [29,61] on
the Sequenom platform, as we have done previously
[32,41,62,63]. These assays are based on single nu-
cleotide polymorphisms (SNPs) that distinguish be-
tween the inbred JF1/Ms (JF1) and 129S1 (129)
mouse strains, or between the JF1 and the TgOG2
(OG2) transgenic mouse strains. Each SNuPE primer
(UEP) abuts a SNP in a target DMR/transcript, and
the incorporating nucleotides differ in molecular mass
between the parental alleles. The abundance of the
extended UEP is quantified by mass spectrometry.
MIRA-enriched samples or amplified cDNA samples were
spotted onto a 384 SpectroCHIP Array. Automated
spectra acquisition was performed in a MassArray
Compact mass spectrometer (Sequenom) using the
Spectroacquire program (Sequenom) and was analyzed by
MassArray Typer v3.4. RNA-mixing standards were
routinely run to verify linear response in measured
versus input allele-specific transcription: for example,
total RNA from JF1 and 129 embryos was mixed in
different percent ratios (0:100, 10:90, 30:70, 50:50,
70:30, 90:10, and 100:0) before cDNA preparation and
Sequenom allelotyping. A true heterozygote DNA sample
was used for DNA skew correction; a 50:50 RNA mix was
used for RNA skew correction. The percentage of DNA
methylation or transcription of each allele in the total
methylation or expression was calculated at each given
SNP. Primers are listed in Additional file 13.
Statistical analysis
All statistical test P values refer to Student’s t-test unless
otherwise noted.Additional files
Additional file 1: Sequenom data tables. (A) Testing the effect of
endocrine-disrupting chemicals (EDs) on imprint erasure. The full dataset
depicted in Figure 2 is provided. (B) Testing the effect of EDs on the
imprint establishment in prospermatogonia by measuring allele-specific
DNA methylation at DMRs in G2 soma. The full dataset depicted in
Figure 3C is provided. (C) Testing the effect of EDs in fetal primary
oocytes by measuring allele-specific DNA methylation at DMRs in G2
soma. The full dataset depicted in Figure 3D is provided. (D) Effect of
EDs on allele-specific expression of imprinted genes in G2 embryos
derived from exposed prospermatogonia. The full dataset depicted in
Figure 4 is provided. (E) Effect of EDs on allele-specific expression of
imprinted genes in larger number of G2 embryos derived from exposed
prospermatogonia. The full dataset depicted in Additional file 2, panel A is
provided. (F) Testing for transgenerational epigenetic inheritance of
aberrant imprinted expression in G3 soma. The full dataset depicted in
Figure 5 is provided. (G) Testing for transgenerational epigenetic inheritance
of aberrant imprinted expression in larger number of G3 fetuses. The full
dataset depicted in Additional file 2, panel B is provided. (H) Effect of EDs on
allele-specific expression of imprinted genes in embryos derived from exposed
primary oocytes. The full dataset depicted in Additional file 3 is provided.
Additional file 2: Analysis of larger number of fetuses. (A) Effect of
EDs on allele-specific expression of imprinted genes in fetuses derived from
exposed prospermatogonia. Average parental allele-specific transcription in
different body parts/organs of three 13.5 dpc G2 fetuses is displayed. The
experiment was conducted as depicted in Figure 3A. Results of RNA
Sequenom allelotyping experiments of selected imprinted transcripts listed
to the left are shown using the color scale as in Figure 2. There were no
statistically significant (P value <0.05) differences between ED and oil
control, greater than 5%. The number (n) of G2 fetuses whose average
values are shown per each ED is indicated. (B) Testing for transgenerational
epigenetic inheritance of the aberrant imprinted expression. Average
parental allele-specific transcription in different body parts/organs of
three 13.5 dpc G3 fetuses is displayed. The experiment was performed
as described in Figure 5A and displayed according to the color scale in
Figure 2B. There were no statistically significant (t-test, P <0.05) differences
between ED and oil control, greater than 5%. The number of G2 fetuses
whose average values are shown per each ED is indicated.
Additional file 3: Effect of EDs on allele-specific expression of
imprinted genes in embryos derived from exposed primary oocytes.
The experiment was conducted as depicted in Figure 3B. Parental
allele-specific transcription is displayed according to the color scale as in
Figure 2. Results of RNA Sequenom allelotyping experiments of imprinted
transcripts listed to the left are shown in different body parts/organs of the
13.5 dpc G2 embryo after ED or oil treatment of the G0 dam. Statistically
significant (P <0.05) differences as compared to oil control greater than
5% and 10% are indicated by thin or bold rectangles, respectively. Note
the strict undisturbed allele-specific transcription. Notice that there is no
causative relationship between aberrant allele-specific DMR methylation
(Figure 3D) and aberrant allele-specific transcription in this Figure.
Additional file 4: Experimental designs for testing the effect of EDs
on the establishment and maintenance of DNA methylation in the
male germ line and for transgenerational inheritance of epigenetic
aberrations. (A, B) Experimental design to directly test the effect of ED
exposure on paternal DNA methylation establishment in the offspring. G1
male offspring of FVB dam and OG2 father was exposed in utero at the time
when paternal imprint establishment occurs in its prospermatogonia and
MAT DMRs are protected from de novo DNA methylation. Exposure
occurred daily from 12.5 dpc to 16.5 dpc by oral gavage to pregnant G0
dams with one of the three different EDs or vehicle control (oil). (A)
Prospermatogonia were collected at 17.5 dpc for DNA methylation analysis
from G1 fetuses by FACS sorting. In these prospermatognia, G1-specific
DNA methylation is erased, and DNA methylation re-establishment is largely
complete, resulting in reprogrammed G1 (G1R) pattern. (B) After
reaching adulthood, G1R spermatozoa (developed from in utero exposed
prospermatogonia) were also collected from G1 (FVBXOG2) males (green
testicles). (C, D) Experimental design to test if perturbing DNA methylation
establishment in prospermatogonia is transgenerationally inherited through
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FVB dam and FVB father was exposed in utero at the time when paternal
imprint establishment occurs in its prospermatogonia and MAT DMRs are
protected from de novo DNA methylation. Exposure occurred daily from
12.5 dpc to 16.5 dpc by oral gavage to pregnant G0 dams with one of the
three different EDs or control oil vehicle. After reaching adulthood G1 male
was mated with OG2 females and from G2 fetuses (derivative of exposed
prospermatogonia, marked by three blue stars) prospermatogonia (never
exposed to EDs) were collected for DNA methylation analysis by FACS
sorting. These spermatogonia carried the reprogrammed G2 (G2R) DNA
methylation pattern. (D) Some G2 (FVBXOG2) males were allowed to
reach adulthood and were used for collecting G2R-type spermatozoa
(developed from never exposed prospermatogonia).
Additional file 5: MIRA-chip profile of imprinted DMRs in G1R and G2R
prospermatogonia. DNA methylation was mapped using MIRA-chip and
custom Nimblegen arrays in prospermatogonia purified by FACS. The MIRA
profile is depicted in the neighborhood of paternally (page 1) and maternally
(page 2) methylated imprinted DMRs (black arrowheads) in biological triplicate
samples for each treatment as indicated on the side. The DNA methylation
signals of MIRA versus input DNA were plotted as -log10 P value scores
ranging from 0 to 8.4 for gestational stage 17.5 dpc. The experiment was
conducted as depicted in Figure 4. Note, that in prospermatogonia,
default establishment of DNA methylation is undisturbed at paternally
methylated DMRS and the protection from DNA methylation establishment
is also undisturbed at maternally methylated imprinted DMRs.
Additional file 6: No transgenerational epigenetic aberrations are
detectable at imprinted DMRs after in utero ED exposure. Samples
(groups 5 to 8) were analyzed from the MIRA-chip experiment conducted
using the custom imprinting arrays (Additional file 7). The average MIRA/
input log2 ratios (n = 3 for MGC and n = 2 for sperm) were measured
along known imprinted DMRs (column A), at the chromosomal locations
indicated (columns B to D). The average values of two conditions were
compared to detect changes along these DMRs with the cutoff values
of ±5% and P <0.05. In the following columns the MIRA/input log2 ratios
of each individual sample are also provided together with standard
deviation values of the Student’s t-test.
Additional file 7: List of MIRA-chip and Affymetrix samples.
Additional file 8: Results of MIRA-chip experiments.
Prospermatogonia of G1 fetuses were treated with ED or oil control in
utero as depicted in Additional file 4. DNA methylation was measured in
purified G1R and G2R prospermatogonia (MGC) at 17.5 dpc and in adult
spermatozoa by MIRA-chip. We used CpG-promoter or custom imprinting
Nimblegen arrays. The analysis was conducted at four levels, as described in
the legend to Table 3. In addition, at level 5, we compared the hits of level
1 to 4 analysis between the two types of arrays. Each peak (chromosomal
coordinates are given in columns F to H) belongs to a level 1 test (column C)
and may belong to a level 2 to 4 tests (column D) between two samples
or two to four level 1 tests (column E). The MIRA intensities in each of the
replicate and the average A and B samples are provided as log2 MIRA/input
ratios (columns I to P). The differences in log2 MIRA/input ratios are given in
column Q with color codes (red increase in A versus B, blue, decrease in
A versus B) with t-test P values, t-test false discovery rates (FDR), Wilcoxon
P values, and Wilcoxon FDRs. In case the MIRA peaks overlapped (+1 kb) with
the upstream, intragenic, or downstream region of known transcripts, these
were annotated using information on strand (±), start and end chromosomal
coordinates, symbol, and accession number.
Additional file 9: MIRA-chip profile at the top hits from a key study
reporting transgenerationally inherited DNA methylation aberrations.
We treated prospermatogonia of G1 fetuses with VZ or oil control in utero
as depicted in Additional file 4, and mapped DNA methylation using
MIRA-chip and CpG-promoter Nimblegen arrays in purified G1R and G2R
prospermatogonia (MGC) at 17.5 dpc and in adult spermatozoa. DNA
methylation signals of MIRA versus input DNA were plotted as -log10
P values ranging from 0 to 8.3 for experimental and control replicate
samples as indicated to the left. The regions represent the top hits from [43]
where these regions exhibited the greatest decrease and increase (Mro and
Elf3, respectively) in sperm of G3 adult males after in utero exposure of
prospermatogonia inside G1 fetuses, and were considered examples for
transgenerational epigenetic aberrations. Note the lack of change in G1Rand G2R MGC and sperm at these locations (black triangles) and the
complete lack of DNA methylation at the Elf3 promoter at all times.
Additional file 10: No transgenerational epigenetic aberrations are
detectable at IAP elements after in utero ED exposure. Samples (groups
5 to 8) were analyzed from the MIRA-chip experiment conducted using the
custom imprinting arrays (Additional file 7). The average MIRA/input log2
ratios (n = 3 for MGCs and n = 2 for sperm) were measured along 1-kb-long
flanking region to each IAP (column A), at the chromosomal locations
indicated (columns B to D), where these flanks were unique sequences. Sheet
1 in the Excel file provides the complete dataset of the level 1 analysis. The
average values of two conditions (average sample A versus average sample
B) were compared along these regions to detect changes with the cutoff
values of ±5% and P <0.05 (Student’s t-test). The MIRA/input log2 ratios of
each individual sample are also provided together with standard deviation
values of the Student’s t-test. Sheet 2 provides the result of the analysis where
common changes were detected between MGC-sperm or between G1R and
G2R samples. Sheet two provides the summary of common hits. In case the
MIRA peaks overlapped (±10 kb) with the upstream, intragenic, or
downstream region of known transcripts, these were annotated using
information on strand (±), start and end chromosomal coordinates, symbol,
and accession number. Note that there were very few immediate and
persistent changes. These were small, often occurred in the opposite
direction between generations, and rarely mapped to known transcripts.
Additional file 11: Search for persistent epigenetic aberrations at IAP
elements. (A) Change in G1R MGC that persists into G2R MGC after in utero
VZ exposure. DNA methylation was measured along each unique 1-kb-long
IAP-flanking region in the MIRA-chip samples as shown at the top. Selected
IAP-flank regions where common changes were detected in MGC samples
between G1R MGC and G2R MGC are shown with chromosomal coordinates.
The criteria for selection was the following: the change between G1R VZ
versus G1R oil and also G2R VZ and G2R oil were at least ±5% with P <0.05
(Student’s t-test). The average MIRA/input log2 ratios (n = 3 for MGC and
n = 2 for sperm) are depicted with red and blue flags in the range of -1.2
to +2.1. In case the MIRA peaks overlapped (±10 kb) with the upstream,
intragenic, or downstream region of known transcripts, these were marked
at the right using strand information (±). (B) Search for epigenetic aberrations
at IAP elements in G1R MGC that persist into G1R sperm after in utero VZ
exposure. The criteria for selection were the following: the change between
MGC G1R VZ versus G1R oil and also between sperm G1R VZ and G2R oil
was at least ±5% with P <0.05. (C) Search for epigenetic aberrations at IAP
elements in G1R sperm that persist into G2R sperm after in utero VZ exposure.
The criteria for selection was the following: the change between sperm G1R
VZ versus G1R oil and also between sperm G2R VZ and G2R oil were at least
±5% with P <0.05. (D) Search for epigenetic aberrations at IAP elements in
G1R MGC that persist into G2R MGC after in utero DEHP exposure. The criteria
for selection were the following: the change between G1R DEHP versus G1R
oil and also G2R DEHP and G2R oil were at least ±5% with P <0.05. (E) Search
for epigenetic aberrations at IAP elements in G1R MGC that persist into G2
MGC after in utero BPA exposure. The criteria for selection were the following:
the change between G1R BPA versus G1R oil and also G2R BPA and G2R oil
were at least ±5% with P <0.05. Note that there were very few immediate
and persistent changes. These were small and often occurred in the opposite
direction between generations (bottom group). The full set of data and
calculations are provided in Additional file 10.
Additional file 12: Common changes of transcription in G1R and
G2R prospermatogonia. (A) Common changes after DEHP treatment.
(B) Common changes after VZ treatment. Full results of the common hits
tabulated in Table 4 is shown. Common changes were detected between
the unique transcripts that change in G1R and G2R samples for the same
treatment using 1.05-fold difference and P <0.05 cutoff values. We marked
those that changed in the same direction.
Additional file 13: List of primers used for Sequenom allelotyping.
Primers are listed for Sequenom experiments. The first PCR primer
(1st-PCRP) and the second PCR primer (2nd-PCRP) were used in the
amplification. UEP_SEQ primers were used in mass spectrometry after
incorporating one or the other allele-specific nucleotide by primer
extension. The DMR18-plex was used for DNA methylation analysis at DMR
regions. The imprinted expression multiplexes were used for allele-specific
transcription analysis at imprinted genes.
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BPA: Bisphenol A; DEHP: Di-(2-ethylhexyl) phthalate; DMR: Differentially
methylated region; ED: Endocrine-disrupting chemical; FDR: False discovery
rate; FGC: Female germ cell; FSC: Female somatic cell; G1R: Generation
1–reprogrammed; G2R: Generation 2-reprogrammed; IAP: Intracisternal
A-particle element; MAT: Maternally methylated; MGC: Male germ cell;
MIRA: Methylated CpG island recovery assay; MSC: Male somatic cell;
PAT: Paternally methylated; PCA: Principal component analysis; PGC: Primordial
germ cells; TGI: Transgenerational inheritance; VZ: Vinclozolin.
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